Investing Profile
Ali Behbahani
VCInvestor
General Partner at New Enterprise Associates (NEA)
nea.com/team/ali-behbahani-mdPhiladelphia, Pennsylvania
Your Intro Paths to Ali Behbahani
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Ali Behbahani on
cbCurrent Investing Position
New Enterprise Associates (NEA) General Partner
Investment Range
$2.0M - $50.0M
Sweet Spot
$25.0M
Investments On Record
15
Current Fund Size
$6.2B
Ali Behbahani is on these Sector & Stage Rankings
Medical Devices (Series B)BioTech (Series A)Health IT (Series A)Medical Devices (Series A)BioTech (Series B)Health & Hospital Services (Series A)Pharmaceuticals (Series A)Health & Hospital Services (Series B)Pharmaceuticals (Series B)Health IT (Series B)Medical Devices (Series B)Medical Devices (Series A)Pharmaceuticals (Series B)Pharmaceuticals (Series A)Washington, D.C.Health & Hospital Services (Series B)BioTech (Series B)Health & Hospital Services (Series A)Health IT (Series B)BioTech (Series A)Health IT (Series A)New York City
Ali Behbahani's Investments On Record (10)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Launchpad Therapeutics | Series ADec 2022$30M  | $30M |
Tune Therapeutics | Series ADec 2021$40M | $40M |
858 Therapeutics | Series ASep 2021$60M | $60M |
Stablix | Series AJun 2021$63M | $63M |
Monte Rosa Therapeutics | Series CMar 2021$95M Series BSep 2020$96M Series AMay 2020$33M | $220M |
Spyglass Ophthalmics | Series BJan 2021$28M Series AMay 2019 | $28M |
Rotation Medical | Series BAug 2016$12M  | $39M |
CRISPR Therapeutics | Funding RoundApr 2015$64M Series BApr 2015$29M Series AApr 2015$35M | $130M |
Investors who invest with Ali Behbahani